These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26049069)

  • 1. Anticoagulant Therapy in Patients with Cirrhosis.
    Intagliata NM; Northup PG
    Semin Thromb Hemost; 2015 Jul; 41(5):514-9. PubMed ID: 26049069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic liver disease and thrombosis risk].
    Aberg F; Lassila R; Ilmakunnas M; Jokelainen K; Numminen K; Mäkisalo H
    Duodecim; 2015; 131(4):321-30. PubMed ID: 26237922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
    Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
    Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
    Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
    Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep vein thrombosis and anticoagulant therapy.
    Sullano MA; Ortiz EJ
    Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes?
    Licinio R; Principi M; Losurdo G; Castellaneta NM; Ierardi E; Di Leo A
    ScientificWorldJournal; 2014; 2014():895839. PubMed ID: 25614899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in anticoagulation therapy in patients with cirrhosis.
    Sasso R; Rockey DC
    Curr Opin Gastroenterol; 2019 May; 35(3):161-167. PubMed ID: 30844894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of thrombosis in the cancer patient.
    Andrea N; Ansell J
    J Support Oncol; 2003; 1(4):235-8, 240-2; discussion 239-40, 243-5. PubMed ID: 15334865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
    Lisman T; Kamphuisen PW; Northup PG; Porte RJ
    J Hepatol; 2013 Aug; 59(2):358-66. PubMed ID: 23548197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going.
    Khoury T; Ayman AR; Cohen J; Daher S; Shmuel C; Mizrahi M
    Digestion; 2016; 93(2):149-59. PubMed ID: 26745654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative management of long-term anticoagulation.
    Kearon C
    Semin Thromb Hemost; 1998; 24 Suppl 1():77-83. PubMed ID: 9840696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy in liver diseases: complication or therapy?
    Bianchini M; De Pietri L; Villa E
    Dig Dis; 2014; 32(5):609-14. PubMed ID: 25034295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful anticoagulation for bilateral central retinal vein occlusions accompanied by cerebral venous thrombosis.
    Lee YH; Lee JY; Kim YS; Kim DH; Kim J
    Arch Neurol; 2006 Nov; 63(11):1648-51. PubMed ID: 17101837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clotting and bleeding: anticoagulant therapy update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2003 Mar; 17(2):83-5. PubMed ID: 12642804
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data.
    Menzin J; Preblick R; Friedman M; Menzin J; Frean M; Jacqueline Kwong W
    Hosp Pract (1995); 2014 Oct; 42(4):59-74. PubMed ID: 25502130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis.
    Rodriguez-Castro KI; Simioni P; Burra P; Senzolo M
    Liver Int; 2012 Nov; 32(10):1465-76. PubMed ID: 22734713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.
    Rosen RL
    J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation in cirrhosis: a new paradigm?
    Leonardi F; Maria N; Villa E
    Clin Mol Hepatol; 2017 Mar; 23(1):13-21. PubMed ID: 28288507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A major research gap: The use of anticoagulants in cirrhosis.
    Senzolo M; Garcia-Pagan JC
    J Hepatol; 2023 Dec; 79(6):1566-1570. PubMed ID: 37302580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splanchnic vein thrombosis in the patient with cirrhosis: Better anticoagulated than not (for most patients).
    Al-Samkari H
    Thromb Res; 2022 Oct; 218():201-202. PubMed ID: 35909016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.